Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9 Stocks Moving In Tuesday's After-Hours Session

RCKT

Gainers

  • Cerus Corporation (NASDAQ: CERS) shares are up 19 percent after the company reports INTERCEPT has met primary and safety endpoints in Phase 3 study.
  • Accuray Incorporated (NASDAQ: ARAY) shares are up 10 percent after reporting a second quarter earnings and sales beat. Second quarter EPS beat estimates by 4 cents. Sales came in at $100 million, topping estimates by $10 million.
  • Net Element Inc (NASDAQ: NETE) shares are up 7 percent. No news was immediately available.

Losers

  • Puma Biotechnology Inc (NASDAQ: PBYI) shares are down 27 percent after the company reports EMA’s CHMP communicated a negative trend vote after meeting to discuss MAA for Neratinib.
  • United Continental Holdings Inc (NYSE: UAL) fell 5 percent following Q4 earnings.
  • Mercury Systems Inc (NASDAQ: MRCY) shares are down 6 percent following a mixed earnings report. Second quarter adjusted EPS came in at 28 cents, missing estimats by 2 cents. Sales beat estimates, coming in at $118 million, beating estimates by $3 million.
  • Rocket Pharmaceuticals Inc (NASDAQ: RCKT) shares are down 8 percent after the company reported an offering of common stock. No amount was disclosed.
  • Texas Instruments Incorporated (NASDAQ: TXN) shares are down 5 percent after reporting fourth quarter earnings that fell in-line with estimates. Sales came in $10 million higher than estimates, at $3.75 billion. The company sees first quarter GAAP EPS of $1.14-$1.17.
  • Strongbridge Biopharma plc (NASDAQ: SBBP) shares are down 5 percent following the announcement of a 5 million common share offering.